The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation
Open accessAbstract
AIMS: To investigate alterations in protein expression associated with deep brain stimulation (DBS) in an attempt to elucidate possible mechanisms of action . METHODS: Cerebrospinal fluid (CSF), obtained from six Parkinson's disease (PD) patients (pre- and post-DBS) and from six normal healthy controls, was studied for differentially expressed proteins. 2-D DIGE, in combination with MALDI-TOF and TOF-TOF Mass Spectrometry (MS) or ESI-MS, was used to identify the changed proteins (3 PD patients and 3 controls). Selected proteins were further studied using western blotting (6 PD patients and 6 controls). RESULTS: Twenty-one proteins were identified after MS and protein database interrogation. Apart from apolipoprotein A-I (apoA-I), the expression levels of complement C4 (C4), IgA, tetranectin, and extracellular superoxide dismutase (EC-SOD), detected by western blotting, correlated well with the 2-D DIGE results. In the follow-up period, the expression levels of C4, apoA-I and IgA were stable whereas EC-SOD and tetranectin were significantly elevated. In addition, when DBS was ceased in one patient due to a suicide attempt, the levels of EC-SOD and tetranectin significantly decreased. CONCLUSION: Our preliminary results suggest that variations in the expression levels of EC-SOD and tetranectin in CSF is related to DBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
On the adaptive control of the false discovery rate in multiple testing with independent statistics
Benjamini, Y., & Hochberg, Y. (2000) · Journal of Educational and Behavioral Statistics · doi:10.3102/10769986025001060 · Cited by 2,015
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
Benabid, A. L., Chabardes, S., Mitrofanis, J., & Pollak, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70291-6 · Cited by 1,285
Deep brain stimulation for Parkinson’s disease
Benabid, A. L. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.11.001 · Cited by 1,046
Alban, A., David, S. O., Bjorkesten, L., Andersson, C., Sloge, E., Lewis, S., & Currie, I. (2003) · PROTEOMICS · doi:10.1002/pmic.200390006 · Cited by 924
Translational principles of deep brain stimulation
Kringelbach, M. L., Jenkinson, N., Owen, S. L. F., & Aziz, T. Z. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2196 · Cited by 853
Extracellular superoxide dismutase in biology and medicine
Fattman, C. L., Schaefer, L. M., & Oury, T. D. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00275-2 · Cited by 651
How Does Deep Brain Stimulation Work? Present Understanding and Future Questions
McIntyre, C. C., Savasta, M., Walter, B. L., & Vitek, J. L. (2004) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200401000-00006 · Cited by 304
Deep Brain Stimulation for the Treatment of Parkinson’s Disease
Volkmann, J. (2004) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200401000-00003 · Cited by 298
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
CLEMMENSEN, I., PETERSEN, L. C., & KLUFT, C. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09586.x · Cited by 218
Treatment of Parkinson's disease.
Hardie, R. J. (1985) · PubMed · Cited by 218
Flaumenhaft, R., Abe, M., Mignatti, P., & Rifkin, D. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.4.901 · Cited by 201
Genetics of Parkinsonʼs disease
Gasser, T. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000170951.08924.3d · Cited by 192
Deep brain stimulation for Parkinson's disease: Patient selection and evaluation
Lang, A. E., & Widner, H. (2002) · Movement Disorders · doi:10.1002/mds.10149 · Cited by 183
Kroksveen, A. C., Opsahl, J. A., Aye, T. T., Ulvik, R. J., & Berven, F. S. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.11.010 · Cited by 176
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
McNaught, K. S. P., & Olanow, C. W. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.012 · Cited by 165
Borregaard, N., Christensen, L., Bjerrum, O. W., Birgens, H., & Clemmensen, I. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114453 · Cited by 154
Protein misfolding in neurodegenerative diseases
Agorogiannis, E. I., Agorogiannis, G. I., Papadimitriou, A., & Hadjigeorgiou, G. M. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00558.x · Cited by 140
Subthalamic Stimulation for Parkinson's Disease
Benabid, A., Koudsié, A., Benazzouz, A., Fraix, V., Ashraf, A., Bas, J. F. L., Chabardès, S., & Pollak, P. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00077-1 · Cited by 137
A potential role for tetranectin in mineralization during osteogenesis.
Wewer, U. M., Ibaraki, K., Schjørring, P., Durkin, M. E., Young, M. F., & Albrechtsen, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1767 · Cited by 132
Deep Brain Stimulation for Parkinson’s Disease
Vitek, J. L. (2002) · Stereotactic and Functional Neurosurgery · doi:10.1159/000068959 · Cited by 128
Neuroproteomics: Expression Profiling of the Brain's Proteomes in Health and Disease
Kim, S. I., Voshol, H., van Oostrum, J., Hastings, T. G., Cascio, M., & Glucksman, M. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023618.35579.7c · Cited by 118
Davidsson, P., Paulson, L., Hesse, C., Blennow, K., & Nilsson, C. L. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200103)1:3<444::aid-prot444>3.0.co;2-q · Cited by 110
Dvorak, H. F., Dickersin, G. R., Dvořàk, A. M., Manseau, E. J., & Pyne, K. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/67.2.335 · Cited by 104
Therapeutic electrical stimulation of the central nervous system
Benabid, A., Wallace, B. A., Mitrofanis, J., Xia, C., Piallat, B., Fraix, V., Batir, A., Krack, P., Pollak, P., & Berger, F. R. (2005) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.10.011 · Cited by 98
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
Davidsson, P., & Sjögren, M. J. C. (2005) · Disease Markers · doi:10.1155/2005/848676 · Cited by 93
Apolipoprotein A ‐ I : Insights from redox proteomics for its role in neurodegeneration
Keeney, J. T. R., Swomley, A. M., Förster, S., Harris, J. L., Rukhsana Sultana, A., & Butterfield, D. A. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200087 · Cited by 82
Wewer, U. M., Iba, K., Durkin, M. E., et al. (1998) · Developmental Biology · doi:10.1006/dbio.1998.8962 · Cited by 79
Plasminogen activator system in human breast cancer
Sumiyoshi, K., Serizawa, K., Urano, T., Takada, Y., Takada, A., & Baba, S. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500303 · Cited by 75
Kluft, C., Jie, A. F. H., Łoś, P., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92616-8 · Cited by 71
Meredith, G. E., Halliday, G. M., & Totterdell, S. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.001 · Cited by 66
Wang, E.-S., Sun, Y. J., Guo, J., Gao, X., Hu, J., Zhou, L., Hu, J., & Jiang, C. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01318.x · Cited by 66
Self-citationDietzmann, K., von Bossanyi, P., Krause, D., Wittig, H., Mawrin, C., & Kirches, E. (2000) · Pathology - Research and Practice · doi:10.1016/s0344-0338(00)80017-5 · Cited by 64
Oxidized glutathione stimulated the amyloid formation of α‐synuclein
Paik, S. R., Lee, D., Cho, H., Lee, E., & Chang, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00081-4 · Cited by 58
Tetranectin immunoreactivity in normal human tissues
Christensen, L., & Clemmensen, I. H. (1989) · Histochemistry and Cell Biology · doi:10.1007/bf00495012 · Cited by 57
Interaction of Tetranectin with Sulphated Polysaccharides and Trypan Blue
Clemmensen, I. H. (1989) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518909091550 · Cited by 52
Localization of extracellular superoxide dismutase in adult mouse brain
Oury, T. D., Card, J. P., & Klann, E. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02103-4 · Cited by 51
Tetranectin: a Novel Secretory Protein from Human Monocytes
Nielsen, H. V., CLEMMENSEN, L., & Kharazmi, A. (1993) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1993.tb01662.x · Cited by 37
Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy
Ishigami, N., Tokuda, T., Ikegawa, M., Komori, M., Kasai, T., Kondo, T., Matsuyama, Y., Nirasawa, T., Thiele, H., Tashiro, K., et al. (2012) · Movement Disorders · doi:10.1002/mds.24994 · Cited by 31
The Role of Protein Misfolding in the Pathogenesis of Human Diseases
Ellisdon, A. M., & Bottomley, S. (2004) · IUBMB Life · doi:10.1080/15216540410001674003 · Cited by 28
Clancy, F. (2005) · Neurology Now · doi:10.1097/01222928-200501020-00010 · Cited by 23
Vitek, J. L. (2004) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200401000-00001 · Cited by 11
Neurostimulation for Parkinson Disease
Deuschl, G. (2009) · JAMA · doi:10.1001/jama.2008.938 · Cited by 9
Høgdall, C. K., Christiansena, M., Christansen, L., et al. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(96)06450-9 · Cited by 6
Cited by
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling
Wang, Y., Branicky, R., Noë, A., & Hekimi, S. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708007 · Cited by 2,182
Optical Deconstruction of Parkinsonian Neural Circuitry
Gradinaru, V., Mogri, M., Thompson, K. R., Henderson, J. M., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1167093 · Cited by 1,526
Adaptive deep brain stimulation in advanced Parkinson disease.
Little, S., Pogosyan, A., Neal, S., Zavala, B., Zrinzo, L., Hariz, M., Foltynie, T., Limousin, P., Ashkan, K., FitzGerald, J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23951 · Cited by 1,374
Affective neuroscience of pleasure: reward in humans and animals
Berridge, K. C., & Kringelbach, M. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1099-6 · Cited by 1,254
Metadata
- Authors
- Wang, E.-S., Yao, H.-B., Chen, Y.-H., Wang, G., Gao, W.-W., Sun, Y.-R., Guo, J.-G., Hu, J.-W., Jiang, C.-C., & Hu, J.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 31
- Issue
- 4-5
- Pages
- 625-637
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2008686569
- Cited by
- 1,176
- References
- 45
- FWCI
- 51.10
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.